Factors Associated With Sensorineural Hearing Loss Among Survivors of Extracorporeal Membrane Oxygenation Therapy

Harvard University, Cambridge, Massachusetts, United States
PEDIATRICS (Impact Factor: 5.47). 07/2005; 115(6):1519-28. DOI: 10.1542/peds.2004-0247
Source: PubMed


To endeavor to explain why some graduates of extracorporeal membrane oxygenation (ECMO) therapy develop sensorineural hearing loss (SNHL) whereas others do not, to study the variability seen in the degree of SNHL, to attempt to explain why some graduates with SNHL experience progressive worsening whereas others do not, and to describe the time course of the onset of SNHL on the basis of identified risk factors.
A retrospective chart review with proportional-hazards regression analysis to identify specific risk factors for SNHL from a list of patient and treatment variables.
Children's Hospital Boston, a pediatric tertiary-care facility and ECMO center.
Neonatal ECMO graduates born in 1986-1994 who survived to discharge and underwent audiologic evaluations (n = 111) and a random sample of ECMO graduates who survived to discharge and did not undergo audiologic evaluations (n = 30).
Audiologic data, including the presence or absence of SNHL, the severity of SNHL at the most recent evaluation, the stability or progressive worsening of hearing (with the first evaluation compared with the most recent evaluation), and the occurrence of delayed-onset SNHL.
Twenty-nine (26%) of 111 ECMO graduates who underwent audiologic testing had SNHL at the last evaluation. Of these 29 subjects with SNHL, 21 (72%) had progressive SNHL, of whom 14 (48%) had delayed-onset SNHL. The age of identification of SNHL ranged from 4 months to 8 years 11 months. Factors identified with proportional-hazards regression analyses as being associated significantly with the time to onset of SNHL were a primary diagnosis of congenital diaphragmatic hernia (hazard ratio: 2.60), length of ECMO therapy (hazard ratio: 7.18), and number of days children received aminoglycoside antibiotics (hazard ratio: 5.56). Kaplan-Meier "time-to-event" curves were constructed to illustrate the time course of onset of SNHL, as affected by each of the variables identified as significant risk factors.
These findings illustrate the need for early, routine, audiologic evaluations throughout childhood for all ECMO graduates. Children at even greater risk for developing SNHL because of a history of congenital diaphragmatic hernia, prolonged ECMO therapy, and/or a lengthy course of aminoglycoside antibiotic therapy should be monitored even more closely throughout childhood, depending on the child's individual risk indicators, as suggested here. On the basis of these risk indicators, efforts can be made to minimize the risk of hearing loss while a child is being treated with ECMO. In addition, these risk indicators can assist with counseling families of ECMO graduates regarding the child's specific risk of developing SNHL and how it can be managed should it occur.

Download full-text


Available from: Henry A. Feldman, Mar 26, 2014
  • Source
    • "). Other risk factors that were found to have a strong association with postnatal hearing loss include ECMO therapy (Cheung et al. 1996; Lasky et al. 1998; Mann & Adams 1998; Fligor et al. 2005), congenital diaphragmatic hernia (Robertson et al. 1998; Masumoto et al. 2007; Javidnia & Vaccani 2009), and PPHN (Hendricks-Muñoz & Walton 1988), although fewer studies focusing on these risk factors were yielded in the literature search. "
    [Show abstract] [Hide abstract]
    ABSTRACT: : The aim of this study was to investigate whether there was evidence-based support for targeted surveillance programs using a risk-factor registry to detect postnatal hearing loss or whether other programs were available that may be more effective than targeted surveillance. Particularly, it addressed questions that arose along the targeted surveillance pathway, including: () the risk factors used to determine a referral, () referral frequencies, () the relationship between risk factors and a postnatal hearing loss, and () other systems that may be more efficient than the use of risk factors. : A systematic literature review was completed in peer-reviewed and non-peer-reviewed databases. : Publications were obtained using the databases MEDLINE, Cumulative Index of Nursing and Allied Health Literature, and Excerpta Medica on line, and by inspecting the reference lists of relevant articles and expert-committee papers. Quality assessment ratings and data extraction were completed by the research team. : In total, 40 articles met the inclusion criteria and were included in this review. The outcomes drawn from these studies were inconclusive as they were based on small sample sizes and largely from single sites only. With this in mind, from the information obtained: () gestational age, low-birth weight, toxoplasmosis, other infections, rubella, cytomegalovirus (CMV), herpes simplex virus infections, craniofacial anomalies, respirator support, and the administration of aminoglycosides were the more commonly reported risk factors in programs; () referral frequency for monitoring appointments was approximately 3%; and () CMV, extracorporeal membrane oxygenation, congenital diaphragmatic hernia, and persistent pulmonary hypertension of the newborn were associated with postnatal hearing loss, whereas, preauricular skin tags and ear pits, low-birth weight, and toxoplasmosis were not. The review also identified that second-phase universal screening programs, CMV screening, and genetic screening should be explored as potential additions or alternatives to targeted surveillance using risk factors. : Further large-scale, population-based research on available programs for the detection of postnatal hearing loss should be conducted to improve present practice and assist with the development of evidence-based guidelines for hearing monitoring.
    Full-text · Article · Sep 2012 · Ear and hearing
  • Source
    • "CDH survival rate. Infants who survive CDH are at risk of brain injury, [123] neurodevelopmental disability [124], hearing loss [125] [126], feeding difficulties [127], gastroesophageal reflux [128] [129], lung disease [130], scoliosis [131], pectus excavatum [131], and recurrence of their diaphragmatic hernia. "
    [Show abstract] [Hide abstract]
    ABSTRACT: CDH and neonatal lung lesions are increasingly diagnosed during fetal life, and expanded use of three-dimensional ultrasound and fetal MRI have improved diagnostic detail and accuracy. Chromosomal abnormalities and severe congenital heart lesions negatively impact CDH outcome, but survival at several centers that have abandoned hyperventilation in favor of strict lung protective strategies exceeds 80% in patients who have isolated CDH. Congenital lung lesions range from small, asymptomatic imaging abnormalities to large, space-occupying lesions that cause fetal hydrops. Symptomatic lesions should be resected during infancy, and resection remains the standard for most asymptomatic lesions. Increasing numbers of reports indicate that small, asymptomatic lesions are being treated with observation and follow-up alone, and maturation of this literature is expected in the years to come.
    Full-text · Article · May 2006 · Surgical Clinics of North America

  • No preview · Article ·
Show more